Kinaxo Gets Grant, Will Collaborate in Cancer PGx Study

Kinaxo will work with partners in Germany on identifying tumor-relevant signal transduction pathways using the firm's phosphoproteomics platform.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories